Using Dynamic 99mTc-GSA SPECT/CT Fusion Images for Hepatectomy Planning and Postoperative Liver Failure Prediction

Annals of Surgical Oncology

Volumn 22, Issue 4, 2015, Pages 1301-1307

  Mao, Yilei ^a   Du, Shunda ^a   Ba, Jiantao ^a   Li, Fang ^a   Yang, Huayu ^a   Lu, Xin ^a   Sang, Xinting ^a   Li, Shaohua ^a   Che, Lu ^a   Tong, Junxiang ^b   Xu, Yiyao ^a   Xu, Haifeng ^a   Zhao, Haitao ^a   Chi, Tianyi ^a   Liu, Fang ^a   Du, Yanrong ^a   Zhang, Xianzhong ^c   Wang, Xuebin ^c   Dong, Jiahong ^b   Zhong, Shouxian ^a   Huang, Jiefu ^a   Yu, Yongming ^d   Wang, Jiping ^e,f   more..

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN; BILIRUBIN; TECHNETIUM 99M; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; END STAGE LIVER DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORMAL HUMAN; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGEON; TREATMENT PLANNING; AGED; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; LIVER; LIVER NEOPLASMS; PATHOLOGY; POSTOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING; TISSUE DISTRIBUTION; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTHY VOLUNTEERS; HEPATECTOMY; HUMANS; LIVER; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOPHARMACEUTICALS; ROC CURVE; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84925534292     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4117-4     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
2. Byam J, Millis M. Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2013;2:22–30.
3. Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future. Semin Cancer Biol. 2011;21:59–69.
4. O’Connor S, Ward J, M Watson, B Momin, LC Richardson. Hepatocellular carcinoma—United States, 2001–2006. MMWR Morbidity and Mortality Weekly Report. 2010; 59:4.
5. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972–8.
6. Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer. 2010;116:1938–46.
7. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40:225–35.
8. Kohn GP, Nikfarjam M. The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection. J Gastrointest Surg. 2010;14:1981–9.
9. Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol. 2012;47:1125–33.
10. 10.Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–206; discussion 1206
11. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355–73.
12. Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257:27–36.
13. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology. 1984;87:1217–21.
14. Akaki S, Mitsumori A, Kanazawa S, Togami I, Takeda Y, Joja I, Hiraki Y. Technetium-99m-DTPA-galactosyl human serum albumin liver scintigraphy evaluation of regional CT/MRI attenuation/signal intensity differences. J Nucl Med. 1998;39:529–32.
15. Miki K, Kubota K, Inoue Y, Vera DR, Makuuchi M. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med. 2001;42:733–7.
16. Virgolini I, Muller C, Klepetko W, Angelberger P, Bergmann H, O’Grady J, Sinzinger H. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand. Br J Cancer. 1990;61:937–41.
17. Du S, Mao Y, Tong J, Li F, Che L, Li S, Yang H, Ba J, Hu N, Xing H, Lu X, Sang X, Zhang X, Wang X, Zhong S. A novel liver function evaluation system using radiopharmacokinetic modeling of technetium-99m-DTPA-galactosyl human serum albumin. Nucl Med Commun. 2013;34:893–9.
18. http://www.awards.frost.com.
19. van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R, Saner FH. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 2008;28:767–80.
20. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.
21. Lee CF, Yu MC, Kuo LM, Chan KM, Jan YY, Chen MF, Lee WC. Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J. 2007;30:333–8.
22. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol. 2009;16:614–22.
23. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94.
24. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–9.
25. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9.
26. de Graaf W, Bennink RJ, Vetelainen R, van Gulik TM. Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation. J Nucl Med. 2010;51:742–52.
27. Ha-Kawa SK, Tanaka Y. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med. 1991;32:2233–40.
28. Iimuro Y, Kashiwagi T, Yamanaka J, Hirano T, Saito S, Sugimoto T, Watanabe S, Kuroda N, Okada T, Asano Y, Uyama N, Fujimoto J. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci. 2010;17:673–81.
29. Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, Ochi H. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med. 1999;40:1652–6.